Effects of S-1 as a second-line chemotherapy for patients with relapsed pancreatic cancer

Adjuvant chemotherapy with gemcitabine is the standard treatment in Japan for patients who have undergone resection of pancreatic cancer. However, few reports have described suitable regimens for patients who present cancer relapse following adjuvant chemotherapy. In the present study, we retrospect...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: ISHIDO, KEINOSUKE, TOYOKI, YOSHIKAZU, KUDO, DAISUKE, KIMURA, NORIHISA, YAMANA, DAISUKE, MIURA, TAKUYA, TSUTSUMI, SHINJI, MUROYA, TAKAHIRO, YOSHIKAWA, TORU, OGASAWARA, HIROSHI, YONAIYAMA, SHINNOSUKE, NARUMI, SHUNJI, HAKAMADA, KENICHI
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2011
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3406543/
https://ncbi.nlm.nih.gov/pubmed/22848308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.412
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki